Simplex Trading
INDP icon

Simplex Trading’s Indaptus Therapeutics INDP Stock Holding History

Simplex Trading’s Portfolio INDP Stock Details INDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-1
Closed -$735 – 8107
2020
Q2 		$0 Hold
1
– – ﹤0.01% 7943
2020
Q1 		$0 Hold
1
– – ﹤0.01% 7887
2019
Q4 		$1K Sell
1
-7
-88% -$9.66K ﹤0.01% 7097
2019
Q3 		$12K Sell
8
-4
-33% -$11.9K ﹤0.01% 6143
2019
Q2 		$113K Sell
12
-24
-67% -$303K ﹤0.01% 4051
2019
Q1 		$591K Buy
36
+16
+80% +$280K ﹤0.01% 2485
2018
Q4 		$344K Buy
+20
New +$273K ﹤0.01% 2585
2018
Q3 		– Hold
0
– – – 7702

Other funds holding INDP

AI
AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Simplex Trading's INDP Position: Q3 2020 in Review

Simplex Trading sold out of Indaptus Therapeutics (INDP) in Q3 2020, closing a stake of 1 share — an estimated $735 sold.

Simplex Trading first reported a position in INDP in Q4 2018 and held it in 7 quarters. The position peaked at $591K in Q1 2019. 24 funds tracked by Wall St. Rank hold INDP as of Q3 2020.

  • Simplex Trading reported no remaining Indaptus Therapeutics position as of Q3 2020 after selling out during the quarter.
  • Simplex Trading sold 1 Indaptus Therapeutics share in Q3 2020, an estimated $735.
  • Simplex Trading first reported a position in Indaptus Therapeutics in Q4 2018 and held it in 7 quarters.
  • Simplex Trading's Indaptus Therapeutics position peaked at $591K in Q1 2019.
  • 24 funds tracked by Wall St. Rank held Indaptus Therapeutics as of Q3 2020.

Based on Simplex Trading's 13F filing for Q3 2020, filed 14 Oct 2020.